Patients with early rheumatoid arthritis who smoke are less likely to respond to treatment with methotrexate and tumor necrosis factor inhibitors: Observations from the Epidemiological Investigation of Rheumatoid Arthritis and the Swedish Rheumatology Register cohorts

Abstract

Among patients with early RA, current cigarette smokers are less likely to respond to MTX and TNF inhibitors.